Currency in USD
Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 7 | 7 | 7 | 8 |
Avg. Estimate | -0.19 | -0.46 | -1.25 | -1.29 |
Low estimate | -0.48 | -0.69 | -2.34 | -2.35 |
High estimate | 1.13 | -0.35 | -0.22 | 0.5 |
Year ago EPS | -0.76 | -0.41 | -1.72 | -1.25 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 7 | 7 | 8 | 8 |
Avg. Estimate | 29.38M | 12.22M | 86.73M | 107.04M |
Low estimate | 6.79M | 4.2M | 25M | 30M |
High estimate | 134.2M | 16.01M | 165M | 272.63M |
Year ago sales | 12.36M | 16.51M | 76.01M | 86.73M |
Sales growth (year/est) | 137.70% | -26.00% | 14.10% | 23.40% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|
Est. EPS | -0.47 | -0.47 | -0.43 | -0.29 |
Actual EPS | -0.76 | -0.41 | -0.2 | -0.42 |
Difference | -0.29 | 0.06 | 0.23 | -0.13 |
Surprise % | -61.70% | 12.80% | 53.50% | -44.80% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | -0.19 | -0.46 | -1.25 | -1.29 |
7 days ago | -0.08 | -0.4 | -1.04 | -0.78 |
30 days ago | -0.08 | -0.4 | -1.04 | -0.78 |
60 days ago | -0.12 | -0.43 | -1.17 | -0.69 |
90 days ago | -0.07 | -0.45 | -1.22 | -1.12 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | 2 | 2 | 1 | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 4 | 5 | 5 | 2 |
Growth estimates | ZYME | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 75.00% | N/A | N/A | N/A |
Next qtr. | -12.20% | N/A | N/A | N/A |
Current year | 27.30% | N/A | N/A | N/A |
Next year | -3.20% | N/A | N/A | N/A |
Next 5 years (per annum) | 11.00% | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |